AdvisorShares MSOS 2x Daily ETF

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

CNBS

YOLO

MSOX

WEED

512690

MSOS

TOKE

SNDL (NASDAQ:SNDL) reported a 4.4% year-over-year decline in net revenue to $196 million and a gross profit decrease of 6.8% to $53 million in its Q1 2026 earnings call. The decline was attributed to challenges in the liquor and cannabis markets, alongside working capital management issues. However, the company anticipates profitability improvements from initiatives aimed at generating over $20 million in incremental operating income this year. SNDL is optimistic about future growth, particularly in international sales, and is actively utilizing its share repurchase program due to perceived undervaluation of shares.

benzinga_article

Amplify Seymour Cannabis ETF

AdvisorShares Pure Cannabis ETF

Roundhill Cannabis ETF

Penghua CSI Alcoholic Drink ETF

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Cambria Cannabis ETF

SNDL

Full Transcript: SNDL Q1 2026 Earnings Call

TLRY

Marijuana stocks initially surged after the U.S. Attorney General's order to reschedule certain cannabis products to Schedule III, but closed sharply lower. The order aims to facilitate research and access to medical cannabis, yet creates confusion regarding regulatory guidance for distribution. Stocks like Tilray and Canopy Growth saw significant declines, reflecting market uncertainty. Analysts suggest the order could improve cash flow for the industry, but the lack of clarity on operational implications may hinder progress toward broader legalization.

Dow Jones

Tilray Brands

Canopy Growth

Grand Banks

Tenaya Therapeutics

Xencor

Daishinku Corp.,

CXApp

Nano Labs

Nebius

GraniteShares 2x Long NBIS Daily ETF

Nippi Inc

MarketWise

Weis Markets

Tradeweb Markets Inc-Class

Canon Inc.

Canna-Global Acquisition

Curaleaf Holdings, Inc.

Clever Leaves

Ubicom Holdings. Inc.

Cannae

Trulieve Cannabis Corp.

The Cannabist Company Holdings Inc.

Global Partners LP

Alliance Resources

VGI Partners Global Investments Ltd.

Daily Journal

New York Times

Charter Hall Long WALE REIT

News

CXAPP INC C/WTS (TO PUR COM)

CANNA GLOBAL ACQUISITION CORP C/WTS (TO PUR COM)

CANNABIST CO HOLDINGS INC.

GLOBAL PARTNERS LP 9.50% FIXED RATE CUM RED PERP SER B

Charter Hall Retail REIT

Charter Hall Group

Charter Hall Social Infrastructure REIT

News Corporation Shs B Chess Depository Interests repr 1 Sh

News Corporation Shs A Chess Depository Interests repr 1 Sh

The cannabis rescheduling is causing celebration - and confusion - as marijuana stocks sell off

GTBIF

TCNNF

CRLBF

CURLF

CRON

VICE

In Pittsburgh on April 8, 2026, an inventor from Bethlehem, Pennsylvania shared his motivation for creating a new type of rolling papers. The inventor expressed the desire for a more efficient design that could enhance the experience for marijuana users. The invention, known as PAK-OF-DESE(PAPERS), aims to streamline the process of rolling cannabis, potentially saving users valuable time and eliminating associated hassles. The innovative papers offer improved functionality and convenience, catering to the needs of cannabis enthusiasts.

Unusual Whales

Green Thumb Industries Inc.

Cresco Labs Inc.

Village Farms

Innovative Industrial Properties

Cronos

Charlotte's Web Holdings, Inc.

Organigram

High Tide

AdvisorShares Vice - ETF

InventHelp Inventor Develops Improved Rolling Papers for Marijuana Smokers (PPU-115)

NCS Analytics has launched NCS Thea, a lending intelligence platform designed for financial institutions to access verified operational data for cash-intensive businesses, particularly in the cannabis sector. This platform translates government compliance data into structured risk signals, aiding in credit decisions without replacing existing underwriting processes. NCS Thea provides insights into cash flow, inventory, and compliance, allowing lenders to assess viability, support underwriting, and monitor portfolios effectively. The platform aims to enhance financial transparency and reduce risks associated with cannabis lending, with plans to expand to other regulated industries.

prnewswire

07:07 ETNCS Analytics Launches NCS Thea, the First-Ever Lending Intelligence Platform Built on Government-Verified Cannabis Data

ATB Cormark Capital Markets analyst Frederico Gomes has maintained a Buy rating on SNDL with a price target of $4.50, while the shares closed at $1.51. Gomes has an average return of -3.5% and a 53.85% success rate. Additionally, Alliance Global Partners also issued a Buy rating for SNDL, but TipRanks reiterated a Hold rating today.

Tip Ranks

ATB Cormark Capital Markets Keeps Their Buy Rating on SNDL (SNDL)

SNDL Inc. reported its financial results for Q4 and full year 2025, achieving record net revenue of $946.4 million, a 2.8% increase year-over-year. Q4 revenue was $252.5 million, down 2.0%. Gross profit reached $258.6 million for the year, with a gross margin of 27.3%. Operating income was $11.8 million for Q4, with positive cash flow of $33.9 million for the year. The company is focused on strategic investments and restructuring to enhance growth and shareholder value, with $252.2 million in cash and no debt as of year-end.

GlobeNewswire

SNDL Reports Fourth Quarter and Full Year 2025 Financial and Operational Results

Sndl Inc. reported its Q4 earnings, highlighting record annual revenue of $946 million, despite a 2% decline in quarterly sales to $252 million. The company achieved breakeven adjusted operating income and doubled free cash flow to $18 million. Cannabis Retail and Operations segments showed strong growth, while the liquor segment faced revenue declines. Sndl maintains a debt-free balance sheet with over $250 million in cash. Management acknowledged market challenges but remains optimistic about future growth and margin resilience, despite potential revenue pressure from retail saturation and legal uncertainties in the U.S.

Sndl Inc. Earnings Call: Profits Rise Amid Headwinds

MJUS

The cannabis sector is currently in earnings season, revealing key insights from company executives. A significant catalyst is the potential rescheduling of cannabis to Schedule III, which would enhance cash flow by allowing expense deductions. CEOs from Curaleaf and Cresco Labs emphasize that this change is likely to occur before the midterm elections, fostering broader reform and improving market conditions. Additionally, the closure of a federal loophole allowing hemp-derived THC products is expected to stabilize prices and shift consumers back to regulated markets, benefiting cannabis companies in the long run.

CabotWealthNetwork

Amplify US Alternative Harvest ETF

Key Cannabis Sector Investing Insights from the Latest Earnings Calls

SNDL shares rose in premarket trading after reporting record revenue for 2025, driven by its cannabis business. Q4 revenue was C$252.5M, a ~2% YoY drop, while full-year revenue reached C$964.4M, marking a ~3% YoY growth. CEO Zach George highlighted new records in income and free cash flow. The cannabis segment grew ~11% YoY, generating C$406.8M. The net loss decreased ~84% to C$15.8M, with Q4 net income of C$9.4M. Gross margin improved to ~28% in Q4 and ~27% for the year, reflecting enhanced profitability.

businessinsider

SNDL rises as cannabis sales drive record 2025 revenue

A conflict has arisen between Housing Works, a nonprofit organization, and a cannabis dispensary owner, highlighting the challenges faced by businesses in this industry that lack access to conventional financial and other support. This incident underscores the difficulties faced by cannabis businesses, with an estimated total revenue of $17.5 billion in the United States in 2021, in navigating regulatory and operational hurdles without the usual resources available to other industries.

Aurora Cannabis

cbdMD

$2.5M dispute between Housing Works and cannabis dispensary owner highlights challenges for businesses in cannabis industry.

AdvisorShares MSOS 2x Daily ETF(MSOX.US)

Full Transcript: SNDL Q1 2026 Earnings Call

The cannabis rescheduling is causing celebration - and confusion - as marijuana stocks sell off

InventHelp Inventor Develops Improved Rolling Papers for Marijuana Smokers (PPU-115)

07:07 ETNCS Analytics Launches NCS Thea, the First-Ever Lending Intelligence Platform Built on Government-Verified Cannabis Data

ATB Cormark Capital Markets Keeps Their Buy Rating on SNDL (SNDL)